Skip to main content

Advertisement

Log in

A novel mechanism for inhibiting proliferation of rheumatoid arthritis fibroblast-like synoviocytes: geniposide suppresses HIF-1α accumulation in the hypoxic microenvironment of synovium

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objective

The excessive proliferation of fibroblast-like synoviocytes (FLSs) is a key inducement for the occurrence and development of rheumatoid arthritis (RA). Hypoxia inducible factor-α (HIF-α) accumulation is involved in the regulation of cell biological functions in the hypoxic microenvironment of synovium. This study aimed to investigate the roles of HIF-α and its level regulator prolyl hydroxylases (PHDs) in FLSs proliferation and to explore the regulatory effect of geniposide (GE).

Materials and methods

Adjuvant arthritis rats and RA-FLSs cell line MH7A were taken as the research objects. MH7A cells were incubated in a hypoxic chamber with 2% O2 for hypoxia treatment. CCK-8, FACS, EdU and Western blot assays were performed to evaluate MH7A cells proliferation. Iron assay was conducted to determine intracellular Fe2+ level.

Results

MH7A cells proliferation was significantly enhanced under hypoxia, accompanied by an increase of HIF-1α level. Decreased HIF-1α level by PX-478 inhibited MH7A cells proliferation. Furthermore, PHD2 was highly expressed in vivo and in vitro, and played a key role in modulation of HIF-1α protein level, which was confirmed by PHD2 inhibitor IOX4 and proteasome inhibitor MG132. GE treatment alleviated synovial hyperplasia in AA rats and inhibited MH7A cells proliferation with a reduction in HIF-1α level. Fe2+ acts as an enzymatic cofactor to control PHD2 activity. Iron assay showed that GE reversed the decline of Fe2+ level in MH7A cells under hypoxia.

Conclusion

GE attenuates abnormal proliferation of RA-FLSs via inhibiting HIF-1α accumulation through enhancement of PHD2 activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46:183–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Rao DA, Gurish MF, Marshall JL, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mankia K, Emery P. Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for prevention. Discov Med. 2015;20:129–35.

    PubMed  Google Scholar 

  4. Ganesan R, Rasool M. Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: current status and future directions. Int Rev Immunol. 2017;36:20–30.

    Article  CAS  PubMed  Google Scholar 

  5. Sun W, Ma J, Zhao H, et al. Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis. Arthritis Res Ther. 2020;22:61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ivan M, Kaelin WG Jr. The EGLN-HIF O2-sensing system: multiple inputs and feedbacks. Mol Cell. 2017;66:772–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Deng W, Feng X, Li X, et al. Hypoxia-inducible factor 1 in autoimmune diseases. Cell Immunol. 2016;303:7–15.

    Article  CAS  PubMed  Google Scholar 

  8. Watts ER, Walmsley SR. Inflammation and hypoxia: HIF and PHD isoform selectivity. Trends Mol Med. 2019;25:33–46.

    Article  CAS  PubMed  Google Scholar 

  9. Hu F, Liu H, Xu L, et al. Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis. Eur J Immunol. 2016;46:742–51.

    Article  CAS  PubMed  Google Scholar 

  10. Ryu JH, Chae CS, Kwak JS, et al. Hypoxia-inducible factor-2α is an essential catabolic regulator of inflammatory rheumatoid arthritis. PLoS Biol. 2014;12: e1001881.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Hu Y, Liu X, Xia Q, et al. Comparative anti-arthritic investigation of iridoid glycosides and crocetin derivatives from gardenia jasminoides ellis in freund’s complete adjuvant-induced arthritis in rats. Phytomedicine. 2019;53:223–33.

    Article  CAS  PubMed  Google Scholar 

  12. Shan M, Yu S, Yan H, et al. A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product. Molecules. 2017;22:1689.

    Article  PubMed Central  Google Scholar 

  13. Li N, Li L, Wu H, Zhou H. Antioxidative property and molecular mechanisms underlying geniposide-mediated therapeutic effects in diabetes mellitus and cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7480512.

    PubMed  PubMed Central  Google Scholar 

  14. Li F, Dai M, Wu H, et al. Immunosuppressive effect of geniposide on mitogen-activated protein kinase signalling pathway and their cross-talk in fibroblast-like synoviocytes of adjuvant arthritis rats. Molecules. 2018;23:91.

    Article  PubMed Central  Google Scholar 

  15. Wang RH, Dai XJ, Wu H, et al. Anti-inflammatory effect of geniposide on regulating the functions of rheumatoid arthritis synovial fibroblasts via inhibiting sphingosine-1-phosphate receptors1/3 coupling gαi/gαs conversion. Front Pharm. 2020;11: 584176.

    Article  CAS  Google Scholar 

  16. Wang Y, Wu H, Deng R, et al. Geniposide downregulates the VEGF/SphK1/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro. Phytother Res. 2021;35:4347–62.

    Article  CAS  PubMed  Google Scholar 

  17. Sun M, Deng R, Wang Y, et al. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: a novel target of geniposide to inhibit angiogenesis. Life Sci. 2020;256: 117988.

    Article  CAS  PubMed  Google Scholar 

  18. Chen JY, Wu H, Li H, et al. Anti-inflammatory effects and pharmacokinetics study of geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 2015;24:102–9.

    Article  CAS  PubMed  Google Scholar 

  19. Dai MM, Wu H, Li H, et al. Effects and mechanisms of geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 2014;20:46–53.

    Article  CAS  PubMed  Google Scholar 

  20. Castelli S, Ciccarone F, Tavian D, et al. ROS-dependent HIF1α activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells. J Exp Clin Cancer Res. 2021;40:94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Li G, Yang T, Chen Y, et al. USP5 sustains the proliferation of glioblastoma through stabilization of CyclinD1. Front Pharm. 2021;12: 720307.

    Article  CAS  Google Scholar 

  22. Kang MS, Ryu E, Lee SW, et al. Regulation of PCNA cycling on replicating DNA by RFC and RFC-like complexes. Nat Commun. 2019;10:2420.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9:24–33.

    Article  CAS  PubMed  Google Scholar 

  24. Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233:233–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Liu N, Feng X, Wang W, et al. Paeonol protects against TNF-α-induced proliferation and cytokine release of rheumatoid arthritis fibroblast-like synoviocytes by upregulating FOXO3 through inhibition of miR-155 expression. Inflamm Res. 2017;66:603–10.

    Article  CAS  PubMed  Google Scholar 

  26. He SD, Huang SG, Zhu HJ, et al. Oridonin suppresses autophagy and survival in rheumatoid arthritis fibroblast-like synoviocytes. Pharm Biol. 2020;58:146–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chen D, Wu YX, Qiu YB, et al. Hyperoside suppresses hypoxia-induced A549 survival and proliferation through ferrous accumulation via AMPK/HO-1 axis. Phytomedicine. 2020;67: 153138.

    Article  CAS  PubMed  Google Scholar 

  28. Bahrami A, Atkin SL, Majeed M, et al. Effects of curcumin on hypoxia-inducible factor as a new therapeutic target. Pharm Res. 2018;137:159–69.

    Article  CAS  Google Scholar 

  29. Chen J, Cheng W, Li J, et al. Notch-1 and notch-3 mediate hypoxia-induced activation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheumatol. 2021;73:1810–9.

    Article  CAS  PubMed  Google Scholar 

  30. Wohlrab C, Kuiper C, Vissers MC, et al. Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells. Hypoxia (Auckl). 2019;7:17–31.

    Article  Google Scholar 

  31. Nguyen TL, Durán RV. Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism. Int J Biochem Cell Biol. 2016;80:71–80.

    Article  CAS  PubMed  Google Scholar 

  32. Wollenick K, Hu J, Kristiansen G, et al. Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling. Nucleic Acids Res. 2012;40:1928–43.

    Article  CAS  PubMed  Google Scholar 

  33. Bagnall J, Leedale J, Taylor SE, et al. Tight control of hypoxia-inducible factor-α transient dynamics is essential for cell survival in hypoxia. J Biol Chem. 2014;289:5549–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Henze AT, Riedel J, Diem T, et al. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res. 2010;70:357–66.

    Article  CAS  PubMed  Google Scholar 

  35. Lee SY, Kim HJ, Oh SC, et al. Genipin inhibits the invasion and migration of colon cancer cells by the suppression of HIF-1α accumulation and VEGF expression. Food Chem Toxicol. 2018;116:70–6.

    Article  CAS  PubMed  Google Scholar 

  36. Tu Y, Li L, Zhu L, et al. Geniposide attenuates hyperglycemia-induced oxidative stress and inflammation by activating the Nrf2 signaling pathway in experimental diabetic retinopathy. Oxid Med Cell Longev. 2021;2021:9247947.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Park YH, Bae HC, Kim J, et al. Zinc oxide nanoparticles induce HIF-1α protein stabilization through increased reactive oxygen species generation from electron transfer chain complex III of mitochondria. J Dermatol Sci. 2018;91:104–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

All the animal experiments were approved by the experimental animal ethics committee of Anhui University of Chinese Medicine (No. AHUCM-rats-2021049).

Funding

This work was supported by the National Natural Science Foundation of China (No 81473400; No 81874360).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Experiment implementation and data analysis were performed by PG, MS, Professor HW, JK, XD and FC. The manuscript was written by PG.

Corresponding author

Correspondence to Hong Wu.

Ethics declarations

Conflict of interest

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gan, P., Sun, M., Wu, H. et al. A novel mechanism for inhibiting proliferation of rheumatoid arthritis fibroblast-like synoviocytes: geniposide suppresses HIF-1α accumulation in the hypoxic microenvironment of synovium. Inflamm. Res. 71, 1375–1388 (2022). https://doi.org/10.1007/s00011-022-01636-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-022-01636-5

Keywords

Navigation